NOT RECOMMENDED

Chelation for autism

Not recommended—no benefit for autism and real risk of serious harm.

Not recommended for the use described below. We include it because people ask about it, and the honest answer matters.

How it works

Chelation uses drugs that bind heavy metals. It is a legitimate treatment for confirmed heavy-metal poisoning, and has been falsely marketed for autism.

What the evidence says, use by use

Evidence is specific to the condition, population and—for devices—the exact product. One label never covers everything.

Autism: Treating autism

Not recommended for this use
Who was studied / who it’s for: Autistic children and adultsWhat this label means: Authoritative guidance or regulators advise against this use, usually because of no benefit, real risk, or both.

FDA warns that no chelation product is approved for over-the-counter use and that chelation marketed for autism is unproven and potentially dangerous; UK guidance says do not use chelation for autism.

Sources: FDA · NICE (UK) · NICE (UK)

Who usually provides it

—

Cautions & things to know

  • Deaths have occurred. Confirmed lead poisoning is a separate medical situation managed by physicians.

Educational, not medical advice. NeuroCoach is an educational and care-navigation resource, not a medical provider. Information about medications, supplements, therapies, devices, clinical trials and community experiences is provided for education and exploration and is not a recommendation, diagnosis or treatment plan. Evidence varies substantially among interventions. Decisions about medical or mental-health treatment should be made with an appropriately qualified healthcare professional. Do not start, stop or change medication, supplements or treatment based solely on information found here.

Sources

Sources checked October 5, 2026. Links support this page; they don’t imply endorsement of NeuroCoach.

  1. Questions and answers on unapproved chelation products FDA
  2. Autism spectrum disorder in under 19s: support and management (CG170) NICE (UK)
  3. Autism spectrum disorder in adults: diagnosis and management (CG142) NICE (UK)